04/10/2023 - Institutional news
On October 7 from 10:00 to 14:30 h comes a new edition of the Open Day of the Barcelona Biomedical Research Park (PRBB) in which researchers will explain firsthand what they do, how they do it and where they do it. The different research centers that are part of the PRBB will offer a wide range of free activities for the whole family. On Saturday morning, children over 12 years old will be able to learn about science from its protagonists with guided tours. From 10:00 to 13:30h we have prepared several routes that will simultaneously tour the building and visit different laboratories. In the case of the Hospital del Mar Research Institute you will be able to visit the Bioinformatics Unit, the laboratoris of stem cell and cancer, immune redirection, applied metabolomics and evolutionary genomics where each of them will explain what their work consists of and the research they are currently doing.
Més informació "OPEN PRBB 2023: On Saturday, October 7, we open the doors again to everyone"
29/09/2023 - Institutional news
We are pleased to announce the official launch of the MARMetabolomics service, a pioneering initiative in the field of metabolomics at the Hospital del Mar Research Institute. MARMetabolomics is an advanced platform developed by the Applied Metabolomics Research Group (LIMA), which has extensive experience in the development of analytical methods for the determination of metabolites (small molecules involved in metabolic reactions that take place in biological systems) in both non-invasive (urine, breast milk, hair or cultures) and invasive (CSF, blood or tissues) matrices and their application in the field of health. The platform is a member of the European Infrastructure for Translational Medicine (EATRIS), the Spanish Metabolomics Network and the multidisciplinary center TECNIO, BAPP.
Més informació "Inauguration of the MARMetabolomics Service at Hospital del Mar Research Institute"
8/08/2023 - Institutional news
Eight projects led by researchers from the institute have been selected in this call. They will analyze diverse aspects, from fighting cancer to neuronal organization and the training needs of the new generations of nurses. The Hospital del Mar Research Institute will receive 2,148,000 euros from the State Agency of Investigation to develop eight research projects. Six of these initiatives include a pre-doctoral contract. In the field of oncology research, Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group, leads the project 'Models for the Study of Hematopoietic and Leukemic Stem Cells in Latent State (DormHSC)', which will receive over half a million euros. The objective is to advance the understanding of the latency state of hematopoietic stem cells through four different experimental models to lay the foundation for strategies to combat treatment-resistant cancer populations.
02/05/23 - Institutional news
The Anti-Doping Laboratory of Catalonia was visited last week by a delegation of the Board of Directors of the Catalan Association of Sports Directors (ACDE). ACDE is an association that brings together leaders, federations and professionals in the world of sport in Catalonia while providing them with the best tools to develop their role and promote excellence in the management and values of sport. The delegation was formed by Pere Sust (President of ACDE), Jordi Durá (Secretary), Francisco Sanahuja, Miquel Torres, Pilar Xifré, Manuel Martínez and Judith Martínez, all of them with extensive and recognized links to Catalan and international sports federations and organizations, and was received by the IMIM management and the Laboratory management. After an introduction of the activities of IMIM and the Laboratory, the attendees visited the Laboratory facilities
24/02/2023 - Institutional news
It is led by Dr. Mario Cáceres, ICREA researcher who joins IMIM-Hospital del Mar in its talent attraction program. The group focuses on the application of the latest techniques in the field of genomics to analyze the relationship between changes in the genome and various fields of health. Dr. Mario Cáceres joins IMIM-Hospital del Mar heading a new research group, the Comparative and Functional Genomics Research Group. The arrival of Dr. Cáceres Aguilar, ICREA researcher, has come about thanks to the talent attraction program launched at the institution to boost the research carried out with top-level researchers.
23/02/2023 - Institutional news
The Associació Catalana de Dirigents de l'Esport (ACDE) awarded the distinction of Best Professional Leader to Dr. Rosa Ventura Alemany, director of the Anti-Doping Laboratory of Catalonia of the Hospital del Mar Institute of Medical Research. The distinction recognizes her work leading the Laboratory, one of the 30 laboratories accredited by the World Anti-Doping Agency in the world, and as coordinator of the Research Group on doping control in sport. It also recognizes the Laboratory's work in conducting doping controls for the 2018 Mediterranean Games in Tarragona, and in the management of athletes' biological passports. Finally, it recognizes the relevant scientific results achieved in recent years by the Research Group coordinated by Dr. Ventura Alemany.
06/02/2023 - Institutional news
The Hospital del Mar Medical Research Institute will lead one of the studies and will also be one of the main partners in the other three. They will receive funding from the European Union's Horizon Europe program. The LIVERATION project, led by surgeons and researchers from IMIM-Hospital del Mar and Hospital del Mar, will analyse the capacity of state-of-the-art radiofrequency equipment to widen resection margins in liver tumour removal surgery The other projects will explore treatment personalisation after surgery for localised colon cancer (Sagittarius); strategies for reducing childhood obesity in the European Union (OBELISK); and the use of innovative community interventions and new technologies to protect the mental health of Europeans (MENTBEST)
24/01/2023 - Institutional news
The study is being led by Dr. Jaume Marrugat, a researcher at the IMIM-Hospital del Mar and coordinator of the Girona Heart Registry (REGICOR). It will analyse the association of the complete genome with the incidence of cardiovascular diseases in people who do not have this pathology and who have been under observation for more than ten years. This is the first project of its kind to be carried out in southern Europe, with a cohort of more than 101,000 participants from all over Spain, and will enable better personalised prevention of these pathologies in the country.
22/12/2022 - Institutional news
The Hospital del Mar Medical Research Institute closes a 2022 in which it has strengthened its commitment to the pursuit of quality and the attraction of scientific talent of excellence and young researchers with initiatives such as the new OpenLab. 2022 has been a year full of good news for IMIM-Hospital del Mar. The research carried out has obtained results of great relevance and has had repercussions not only in scientific publications, but also in our society.
22/12/2022 - Institutional news
The European Medicines Agency selected Hospital del Mar Medical Research Institute and the Hospital del Mar to be a Data Partner of the DARWIN EU® data network, an EU-wide federated network of high-quality observational healthcare databases across Europe, that provides expertise and services to support regulatory decision-making throughout the lifecycle of medicinal products. The Hospital del Mar and the Hospital del Mar Medical Research Institute (IMIM) is one of the first eight European centres currently selected to participate in the European Union's DARWIN EU® initiative to carry out multicentre observational studies on medicines. The data available to these partners will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact